MASS: 23% Q2 revenue growth, 57% adjusted gross margin, and strong cash position drive outlook
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw 23% revenue growth and a 57% adjusted gross margin, with a strong cash position and no debt. Strategic focus on handheld chemical analysis and recurring revenue, bolstered by the NIRLab acquisition, positions the company for continued growth.Original document: 908 Devices Inc. [MASS] Slides Release — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw 23% revenue growth and a 57% adjusted gross margin, with a strong cash position and no debt. Strategic focus on handheld chemical analysis and recurring revenue, bolstered by the NIRLab acquisition, positions the company for continued growth.
Original document: 908 Devices Inc. [MASS] Slides Release — Aug. 11 2026